Skip to content

Advance Ultra-Congruent Tibial Insert

by Wrightmedicaltechnologyinc 510(k)

Active United States

510(k) K972770

Overview

The Advance Ultra-Congruent Tibial Insert is a semi-constrained, cemented knee prosthesis designed for total knee replacement. Classified as a Prosthesis, Knee, Patellofemorotibial (product code JWH), it is manufactured from ultra-high molecular weight polyethylene (UHMWPE) and intended to replace damaged tibial surfaces within the knee joint. This insert provides enhanced congruency to improve joint stability and functional restoration during arthroplasty procedures.

This device is supplied as a single-use component and requires cement fixation during implantation. It is intended for use in orthopedic settings under sterile conditions, adhering to standard surgical protocols for knee arthroplasty. The Advance Ultra-Congruent Tibial Insert holds an FDA 510(k) clearance (K972770) under the Traditional review pathway, classified as Class II with Special Controls. Compliance with regulatory guidelines ensures safe integration into total knee replacement systems.

AI-generated from registry data, 1 Oct 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK972770 Date21 Oct 1997ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls

2 recalls · FDA

  • 2 recalls, same reason

    • Terminated Z-1636-2010 FDA Unclassified (pre-2012) initiated 24 Nov 2009
    • Terminated Z-1637-2010 FDA Unclassified (pre-2012) initiated 24 Nov 2009

    The left medial pivot and right medial pivot inserts were co-mingled

Specification

510(k)

510(k) Number
FDA Product Code
JWH
Device Class
Class II
Regulation
21 CFR Part 888.3560
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Other devices from Wrightmedicaltechnologyinc

See all devices from Wrightmedicaltechnologyinc →

Questions

  • What is the Advance Ultra-Congruent Tibial Insert used for?

    The Advance Ultra-Congruent Tibial Insert is designed to replace damaged tibial surfaces within the knee joint during total knee replacement (arthroplasty). Its semi-constrained, cemented design enhances joint stability and functional restoration, making it ideal for patients requiring improved congruency and alignment in their knee prosthesis.

  • How is the Advance Ultra-Congruent Tibial Insert supplied and implanted?

    This tibial insert is supplied as a single-use component and requires fixation using bone cement during surgical implantation. It is intended for use in orthopedic settings under sterile conditions, following standard knee arthroplasty protocols to ensure proper integration and function.

  • What material is the tibial insert made from, and why is it significant?

    The insert is manufactured from ultra-high molecular weight polyethylene (UHMWPE), a durable and biocompatible material known for its wear resistance and longevity in joint replacements. This material choice helps reduce friction and wear in the knee joint, contributing to long-term stability and performance.

  • Is the Advance Ultra-Congruent Tibial Insert reusable or single-use?

    The tibial insert is explicitly designed for single-use only. This ensures sterility and reduces the risk of cross-contamination or degradation from repeated sterilization processes, aligning with best practices for orthopedic implants.

  • What regulatory clearance does the Advance Ultra-Congruent Tibial Insert hold?

    The device holds FDA 510(k) clearance (K972770) under the Traditional review pathway, classified as Class II with Special Controls. This clearance confirms its compliance with regulatory standards for knee prostheses, ensuring safe use in clinical settings.